Product image of Lidofon Morango (Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride) supplied by GNH India

Lidofon Morango

Active Ingredient:
Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride
Origin:
EU

Lidofon Morango (Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride)

Chlorhexidine Dihydrochloride and Lidocaine Hydrochloride, the active ingredients in Lidofon Morango, are antiseptic and local anesthetic agents presented as a buccal preparation for oral mucosal use. They help manage oral infections and provide pain relief in the mouth, particularly for conditions such as mouth ulcers and dental pain.

GNH India supplies Lidofon Morango as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medinfar Consumer Health - Produtos Farmacêuticos,lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lidofon Morango combines chlorhexidine and lidocaine to address oral mucosal infections and associated pain.

  • Oral mucosal infections: reduces microbial load and promotes healing of the oral lining.
  • Dental pain: provides rapid local anaesthesia to relieve discomfort during or after dental procedures.
  • Mouth ulcers: alleviates pain and helps prevent secondary bacterial infection.

How It Works

  • Chlorhexidine Dihydrochloride disrupts bacterial cell membranes, leading to loss of cellular integrity and antiseptic activity. Lidocaine Hydrochloride blocks voltage‑gated sodium channels in peripheral nerves, preventing depolarisation and producing a reversible local anaesthetic effect on the oral mucosa.

Side Effects

Lidofon Morango may cause local reactions when applied to the oral mucosa.

Common Side Effects

  • Altered taste sensation: temporary metallic or bitter taste.
  • Mild oral irritation: slight burning or tingling at the application site.
  • Transient numbness: short‑lasting loss of sensation in the treated area.
  • Dry mouth: reduced salivation during use.

Serious or Rare Side Effects

  • Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention.
  • Persistent mucosal ulceration: prolonged ulcer formation beyond normal healing.
  • Systemic toxicity: rare signs of lidocaine overdose such as dizziness or cardiac effects.
  • Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.
  • Significant bleeding: unusual bleeding if mucosal integrity is compromised.

Precautions & Warnings

Before using Lidofon Morango, consider the following safety measures.

  • Allergy assessment: avoid if the patient has known hypersensitivity to chlorhexidine or lidocaine.
  • Open wounds: do not apply to extensive oral lesions or deep tissue injuries.
  • Concurrent anesthetics: limit use with other topical anaesthetics to prevent cumulative toxicity.
  • Professional supervision: use only under direction of a qualified healthcare provider.
  • Monitor irritation: discontinue if severe irritation or allergic signs develop.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lidofon Morango may interact with other medications or products applied to the oral cavity.

Major Interactions (Avoid)

  • Concurrent topical anesthetics: may increase systemic lidocaine exposure.
  • Additional chlorhexidine products: can cause additive mucosal irritation.
  • Systemic local anaesthetics: risk of cumulative toxicity when used together.

Moderate Interactions (Monitor Closely)

  • Alcohol‑based mouthwashes: may enhance burning sensation.
  • Anticoagulants: monitor for increased bleeding if mucosal ulceration occurs.
  • Other oral antiseptics: may alter the effectiveness of chlorhexidine component.

Frequently Asked Questions

Lidofon Morango is formulated to treat oral mucosal infections, relieve dental pain, and reduce discomfort from mouth ulcers. It combines an antiseptic with a local anaesthetic to both control microbial growth and provide temporary numbness in the treated area.

Chlorhexidine disrupts bacterial cell membranes, leading to rapid antiseptic action, while lidocaine blocks voltage‑gated sodium channels in nerve fibers, preventing signal transmission and producing a reversible local anaesthetic effect on the oral mucosa.

The appropriate dose and frequency are determined by the prescribing clinician based on the specific indication, severity of symptoms, and patient factors. Patients should follow the healthcare professional’s instructions and not alter the regimen on their own.

Safety information for pregnancy and lactation has not been definitively established. Clinicians should weigh potential benefits against possible risks and consider alternative therapies if there are concerns about exposure to the active ingredients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑ingredient antiseptics, Lidofon Morango pairs chlorhexidine’s broad‑spectrum antimicrobial activity with lidocaine’s local anaesthetic effect, offering both infection control and immediate pain relief. This dual action can be advantageous over products that address only one of these needs.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and extreme temperatures to maintain stability and efficacy.

The preparation is applied directly to the affected oral mucosa using a swab or applicator as directed by a healthcare professional. It is intended for buccal use only and should not be swallowed in large quantities.

Serious risks include severe allergic reactions such as anaphylaxis, persistent numbness, systemic lidocaine toxicity, and rare severe skin reactions like Stevens‑Johnson syndrome. Any signs of these conditions require immediate medical attention.

Individuals with known hypersensitivity to chlorhexidine, lidocaine, or any component of the formulation should avoid using the product. It is also contraindicated in patients with extensive oral lesions where the mucosa is severely compromised.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT